EMEA-001518-PIP03-19
Key facts
| Active substance |
|
| Therapeutic area |
Oncology
|
| Decision number |
P/0419/2019
|
| PIP number |
EMEA-001518-PIP03-19
|
| Pharmaceutical form(s) |
Coated tablet
|
| Condition(s) / indication(s) |
Treatment of Familial Adenomatous Polyposis
|
| Route(s) of administration |
Oral use
|
| Contact for public enquiries |
Cancer Prevention Pharma (Ireland) Limited
E-mail: cbrannen@canprevent.com |
| Decision type |
RP: decision refers to a refusal on a proposed Paediatric Investigation Plan
|